Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
⏸️ ASX Shares
10 top ASX shares to buy in 2020
Share Market News
Why you should add this ASX healthcare company to your Christmas wish list
Share Market News
Are these the best blue chip ASX shares to buy right now?
⏸️ ASX Shares
Why I would buy and hold Afterpay and these ASX shares
Share Market News
Leading brokers name 3 ASX shares to sell today
Share Market News
Why the Medical Developments share price is up 50% since October
52-Week Highs
Why Cochlear and these ASX shares just hit 52-week highs
Record Highs
Ansell shares jump to new record high as ASX 200 soars
Growth Shares
3 high quality ASX healthcare shares to buy in 2020
Share Market News
Why Sigma Healthcare shares have surged 25% higher in November
52-Week Highs
Why these 3 ASX 200 stocks are at 52-week highs
Share Market News
3 ASX 200 events you missed on Wednesday
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
